EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Hemolytic Anemia Linked to Epstein–Barr Virus Infectious Mononucleosis: A Systematic Review of the Literature

Dario F Meloni, Pietro B Faré, Gregorio P Milani iD, Sebastiano A G Lava iD, Mario G Bianchetti, Samuele Renzi, Massimiliano Bertacchi, Lisa Kottanattu, Gabriel Bronz iD, Pietro Camozzi

Journal of Clinical Medicine · 15.02.2025 · 14 (4) · 1283

DOI: 10.3390/jcm14041283 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.02.2025. Verfasst von Dario F Meloni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Family Medicine, Faculty of Biomedical Sciences, Università Della Svizzera Italiana, 6900 Lugano, Switzerland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian ministry of health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Epstein–Barr virus infectious mononucleosis, hemolytic anemia occasionally occurs.

Methods

To characterize hemolytic anemia linked to Epstein–Barr virus infectious mononucleosis, we performed a systematic review (PROSPERO CRD42024597183) in the United States National Library of Medicine, Excerpta Medica, and Web of Science with no restrictions on language. Only reports published since 1970 were included. Eligible were reports describing hemolytic anemia in subjects with clinical signs and microbiological markers of Epstein–Barr virus mononucleosis.

Results

In the literature, we detected 56 reports released between 1973 and 2024, documenting 60 individuals (32 females and 28 males; 27 children and 33 adults) with hemolytic anemia linked to Epstein–Barr virus infectious mononucleosis. The mechanism underlying anemia was categorized as cold-antibody-mediated (N = 31; 52%), warm-antibody-mediated (N = 18, 30%), mixed warm- and cold-antibody-mediated (N = 4; 6.7%), or paroxysmal cold hemoglobinuria (N = 2; 3.3%). The remaining 5 cases (8.3%) remained unclassified. Observation alone was the chosen approach in 23% of cases (N = 14). Steroids (67%; N = 40) and blood transfusions (38%; N = 23) were the most commonly used treatment, while plasma exchange, intravenous polyclonal immunoglobulin, rituximab, and splenectomy were used less frequently. Observation was slightly but significantly (p = 0.032) more common in cases of cold-antibody-mediated anemia compared to all other cases combined. Patients recovered a median of 28 [interquartile range 21–39] days after disease onset. Two patients with warm-antibody-mediated hemolytic anemia died.

Conclusions

This literature review points out that Epstein–Barr virus, like Mycoplasma pneumoniae, cytomegalovirus, or severe acute respiratory syndrome coronavirus 2, may act as a trigger for immune-mediated hemolytic anemia.

Schlagwörter

Stichwörter der Autor:innen

Epstein–Barr viruscold antibodieshemolysisinfectious mononucleosiswarm antibodies

Autor:innen und Institutionen

  • Family Medicine, Faculty of Biomedical Sciences, Università Della Svizzera Italiana, 6900 Lugano, Switzerland.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Pediatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Clinical Sciences and Community Health, Università Degli Studi di Milano, 20122 Milan, Italy.
  • Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1011 Lausanne, Switzerland.
  • Division of Hematology and Oncology, CHUL-Laval, Quebec City, QC G1V 0A6, Canada.

ORCID-Profile: Gregorio P Milani, Sebastiano A G Lava, Gabriel Bronz

Förderung

  • Italian ministry of health

Zitieren

APA

Meloni, D. F., Faré, P. B., Milani, G. P., Lava, S. A. G., Bianchetti, M. G., Renzi, S., Bertacchi, M., Kottanattu, L., Bronz, G., & Camozzi, P. (2025). Hemolytic Anemia Linked to Epstein–Barr Virus Infectious Mononucleosis: A Systematic Review of the Literature. Journal of Clinical Medicine, 14(4), 1283. https://doi.org/10.3390/jcm14041283

Vancouver

Meloni DF, Faré PB, Milani GP, Lava SAG, Bianchetti MG, Renzi S, et al. Hemolytic Anemia Linked to Epstein–Barr Virus Infectious Mononucleosis: A Systematic Review of the Literature. Journal of Clinical Medicine. 2025;14(4):1283. doi:10.3390/jcm14041283

BibTeX
@article{Meloni2025,
  author = {Meloni, Dario F and Faré, Pietro B and Milani, Gregorio P and Lava, Sebastiano A G and Bianchetti, Mario G and Renzi, Samuele and Bertacchi, Massimiliano and Kottanattu, Lisa and Bronz, Gabriel and Camozzi, Pietro},
  title = {Hemolytic Anemia Linked to Epstein–Barr Virus Infectious Mononucleosis: A Systematic Review of the Literature},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1283},
  doi = {10.3390/jcm14041283}
}
Kostenlos starten →